1. Home
  2. INZY vs CTRN Comparison

INZY vs CTRN Comparison

Compare INZY & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • CTRN
  • Stock Information
  • Founded
  • INZY 2015
  • CTRN 1946
  • Country
  • INZY United States
  • CTRN United States
  • Employees
  • INZY N/A
  • CTRN N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • CTRN Clothing/Shoe/Accessory Stores
  • Sector
  • INZY Health Care
  • CTRN Consumer Discretionary
  • Exchange
  • INZY Nasdaq
  • CTRN Nasdaq
  • Market Cap
  • INZY 255.3M
  • CTRN 280.0M
  • IPO Year
  • INZY 2020
  • CTRN 2005
  • Fundamental
  • Price
  • INZY $3.99
  • CTRN $29.22
  • Analyst Decision
  • INZY Buy
  • CTRN Buy
  • Analyst Count
  • INZY 9
  • CTRN 2
  • Target Price
  • INZY $15.22
  • CTRN $24.50
  • AVG Volume (30 Days)
  • INZY 1.3M
  • CTRN 132.6K
  • Earning Date
  • INZY 08-05-2025
  • CTRN 06-03-2025
  • Dividend Yield
  • INZY N/A
  • CTRN N/A
  • EPS Growth
  • INZY N/A
  • CTRN N/A
  • EPS
  • INZY N/A
  • CTRN N/A
  • Revenue
  • INZY N/A
  • CTRN $768,518,000.00
  • Revenue This Year
  • INZY N/A
  • CTRN $6.80
  • Revenue Next Year
  • INZY N/A
  • CTRN $4.61
  • P/E Ratio
  • INZY N/A
  • CTRN N/A
  • Revenue Growth
  • INZY N/A
  • CTRN 1.85
  • 52 Week Low
  • INZY $0.72
  • CTRN $13.66
  • 52 Week High
  • INZY $6.24
  • CTRN $34.63
  • Technical
  • Relative Strength Index (RSI)
  • INZY 83.59
  • CTRN 51.47
  • Support Level
  • INZY $3.94
  • CTRN $32.03
  • Resistance Level
  • INZY $3.97
  • CTRN $30.43
  • Average True Range (ATR)
  • INZY 0.01
  • CTRN 1.48
  • MACD
  • INZY -0.10
  • CTRN -0.60
  • Stochastic Oscillator
  • INZY 100.00
  • CTRN 36.65

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About CTRN Citi Trends Inc.

Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.

Share on Social Networks: